This site is intended for healthcare professionals
Latest drug news
  • Home
  • /
  • News
  • /
  • 2013
  • /
  • 04
  • /
  • FDA recommends Trulign Toric (Bausch & Lomb) for C...
Drug news

FDA recommends Trulign Toric (Bausch & Lomb) for Cataract surgery

Read time: 1 mins
Last updated:10th Apr 2013
Published:10th Apr 2013
Source: Pharmawand

The FDA's Ophthalmic Devices Panel voted 10-1 to recommend the approval of Bausch & Lomb Opthalmic's Trulign Toric intraocular lens to repair vision after Cataract surgery. The Trulign Toric intraocular lens is a multi-piece implant inserted into the capsular bag of the eye to correct problems stemming from cataract removal, restoring vision without spectacles.

The filing is based on a clinical study that included 229 patients, 227 of whom received a lens implant in one eye. The results showed that the Truligh Toric improved visual acuity with low rates of adverse events.

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.